The RNAi Pesticides Market Size is valued at USD 1.08 Bn in 2023 and is predicted to reach USD 2.99 Bn by the year 2031 at an 13.8% CAGR during the forecast period for 2024-2031.
Sustainable agriculture is increasingly adopting innovative solutions like RNA interference (RNAi) to manage plant pests and diseases with minimal environmental impact. RNAi, a natural gene-silencing mechanism, can be applied topically using double-stranded RNA (dsRNA) to target and suppress essential genes in pests. Over the past decade, RNAi has shown great potential as a pest control method, protecting without genetic modification. RNAi's sequence-specific nature makes it particularly promising, allowing it to target species-specific genes. By focusing on genes critical for the growth, development, or reproduction of pest insects, RNAi could selectively eliminate pests while minimizing harm to non-target species, making it a low-risk alternative for pest control.
The EU is currently reviewing its pesticide regulations to determine whether they sufficiently address the emerging category of RNAi pesticides, with growing support for a specific regulatory framework to evaluate this technology's potential risks and benefits. Simultaneously, the U.S. Environmental Protection Agency (EPA) is proposing a three-year approval for a new RNAi-based biopesticide to control the Colorado potato beetle on potato crops. This signals that RNAi pesticides are moving closer to approval in the U.S., reflecting the growing global interest in these innovative pest control solutions. Regulatory bodies, such as the EPA and the European Union, are showing institutional support for safer and more sustainable pest control methods. Ongoing progress in RNAi delivery methods, such as the topical application of double-stranded RNA (dsRNA), is making RNAi pesticides more practical and effective, further enhancing their commercial viability.
Competitive Landscape
Some of the Major Key Players in the RNAi Pesticides Market are
- Bayer
- Cibus
- DuPont
- RNAiSSANCE AG
- Syngenta Crop Protection AG
- GreenLight Biosciences, Inc.
- TRILLIUM AG
- Innatrix Inc.
- Renaissance BioScience Corp.
- Pebble Labs
- AgroSpheres
- Vestaron Corporation
- Elemental Enzymes Inc.
- Invaio Sciences, Inc
Market Segmentation
The RNAi Pesticides Market is segmented based on the application, crop type, product, distribution channel, and formulation. Based on the application, the market is divided into insect pest control, weed management, disease management, and resistance management. Based on the crop type, the market is divided into agricultural applications and non-agricultural applications. Based on the product, the market is categorized into tropical RNAI pesticides, seed-embedded rani, transgenic RNAI, and others. Based on the formulation, the market is segmented into liquid formulation, granular formulation, powder formulation, and others.
The Insect Pest Control Segment is Expected to Have the Highest Growth Rate During the Forecast Period
Based on the application, the market is divided into insect pest control, weed management, disease management, and resistance management. Among these, the insect pest control segment is expected to have the highest growth rate during the forecast period. RNAi technology allows for precise targeting of specific genes that are vital for the survival, growth, reproduction, or development of insect pests. This gene-specific approach enables RNAi pesticides to focus on harmful insect species without affecting non-target organisms, such as beneficial insects, pollinators, or humans. This level of precision is particularly effective for insect control. Insect pests are one of the leading causes of crop damage and loss in agriculture. Traditional pesticides often face limitations in managing resistant insect populations, while RNAi offers a new, more sustainable method of controlling these pests by interfering with key biological processes, such as growth or reproduction.
The Agricultural Application Segment Dominates the Market
Based on the crop type, the market is divided into agricultural applications and non-agricultural applications. Among these, the agricultural application segment dominates the market. Agriculture faces constant challenges from pests, diseases, and weeds that can drastically reduce crop yields. Insect pests, fungi, and other threats cause significant economic losses each year, and traditional chemical pesticides often have limitations. RNAi pesticides offer a more targeted, efficient, and sustainable method to protect crops, making them a crucial agricultural sector tool.
North America Has the Largest Market Share During the Forecast Period.
North America, especially the U.S., has seen early support from regulatory bodies like the Environmental Protection Agency (EPA) for RNAi pesticides. For example, the EPA has proposed limited approvals for RNAi-based pesticides, such as those targeting the Colorado potato beetle. This regulatory support fosters a favourable environment for the commercial development and use of RNAi pesticides. Many insect pests have developed resistance to conventional chemical pesticides. RNAi offers a novel mechanism of action by targeting essential genes, making it less likely for pests to develop resistance. This makes RNAi an attractive solution for managing resistant insect populations and extending the effective life of pest control strategies.
Recent Developments:
- In September 2024, FMC Corporation, declared a new research partnership with AgroSpheres, a biotech company. Accelerating the development of innovative bioinsecticides is the goal of this relationship, which aligns with FMC's long-term strategic goals. The partnership will combine FMC's robust testing and market introduction skills with AgroSpheres' biodegradable encapsulation technology for RNA-based crop protection. This project expands on FMC Ventures' previous investment in AgroSpheres, demonstrating FMC's continued dedication to promoting sustainable agriculture.
- In May 2023, Renaissance BioScience Corp. declared that the company's field study application for its environmentally safe and sustainable RNA interference (RNAi) biopesticide delivery technology has been accepted by the Pest Management Research Agency (PMRA) of the Government of Canada. After carefully examining the company's large data file, the PMRA granted authorization, demonstrating a shared understanding of the nature, promise, and minimal risk of the RNAi technology.
RNAi Pesticides Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD 1.08 Bn |
Revenue Forecast In 2031 |
USD 2.99 Bn |
Growth Rate CAGR |
CAGR of 13.8% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
Application, Crop Type, Product, Distribution Channel, and Formulation |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
Competitive Landscape |
Bayer, Cibus, DuPont, RNAiSSANCE AG, Syngenta Crop Protection AG, GreenLight Biosciences, Inc., TRILLIUM AG, Innatrix Inc., Renaissance, BioScience Corp., Pebble Labs, AgroSpheres, Vestaron Corporation, Elemental Enzymes Inc., Invaio Sciences, Inc. |
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |